Filing Details
- Accession Number:
- 0001104659-20-033114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-13 16:07:45
- Reporting Period:
- 2020-01-01
- Accepted Time:
- 2020-03-13 16:07:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Fortress Biotech Inc. | FBIO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772558 | Kevin Lorenz | C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2020-01-01 | 50,000 | $0.00 | 164,582 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service.
- Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019.
Billionaire Hedge Funds
